£3.5M
Sartorius took a minority shareholding in the London startup through its corporate venture unit to support product commercialisation.
SB
SPARTA Biodiscovery
SPARTA Biodiscovery provides analytical technology for characterising nanoparticles used in vaccines and gene therapies.
White City, London, UK
£3.5MTotal raised
SPARTA Biodiscovery is a spin-out from Imperial College London that develops analytical platforms for characterising nanoparticles used in advanced medicines. Its technology uses Raman spectroscopy to analyse single particles rapidly and automatically.
Categories
Founders
JP
Jelle Penders
CEO
MS
Molly Stevens
Professor
Investors
S
SartoriusLead